Results 51 to 60 of about 1,026 (162)

Plant‐Based Mycetoma Inhibitors Targeting the 50S Ribosomal Protein of Nocardia brasiliensis: In Silico Approach

open access: yesChemistrySelect, Volume 10, Issue 21, June 4, 2025.
In‐silico drug discovery pipeline for Mycetoma caused by Nocardia brasiliensis. A library of 1034 phytocompounds was screened to identify potent inhibitors, with Parviflorone F showing strong binding and stability against the 50S ribosomal unit. Molecular dynamics confirmed its inhibitory potential, offering a promising therapeutic candidate.
Sandra Jose   +7 more
wiley   +1 more source

Repurposing FDA-Approved Drugs for Eumycetoma Treatment: Homology Modeling and Computational Screening of CYP51 Inhibitors [PDF]

open access: yesInternational Journal of Molecular Sciences
Magdi Awadalla Mohamed   +2 more
exaly   +2 more sources

Coexistent actinomycosis and eumycetoma in an immunocompetent patient

open access: yesIndian Journal of Dermatology, 2014
the patient may have taken, or due to the coloring agent titanium dioxide present in the tablet of levocetirizine. However, detailed history taking excluded possibility of both, as there was no other drug intake during last 4 weeks. Also, the patient did not develop any reaction on provocation with fexofenadine, which contained titanium dioxide.
Nagendra Singh Beniwal   +5 more
openaire   +3 more sources

Spinal Eumycetoma: A Rare Cause of Lumbar Canal Stenosis and Significance of “Dot in Circle”

open access: yesIndian Journal of Radiology and Imaging, 2021
Mycetoma is a chronic granulomatous disease that is more common in tropical regions with predominant involvement of foot. Spinal mycetoma presenting as lumbar canal stenosis is extremely rare.
Radha Sarawagi   +3 more
doaj   +1 more source

Posaconazole treatment of refractory eumycetoma and chromoblastomycosis [PDF]

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 2005
Eumycetoma and chromoblastomycosis are chronic, disfiguring fungal infections of the subcutaneous tissue that rarely resolve spontaneously. Most patients do not achieve sustained long-term benefits from available treatments; therefore, new therapeutic options are needed.
Negroni, Ricardo   +5 more
openaire   +4 more sources

The development of a novel diagnostic PCR for Madurella mycetomatis using a comparative genome approach.

open access: yesPLoS Neglected Tropical Diseases, 2020
BackgroundEumycetoma is a neglected tropical disease most commonly caused by the fungus Madurella mycetomatis. Identification of eumycetoma causative agents can only be reliably performed by molecular identification, most commonly by species-specific PCR.
Wilson Lim   +8 more
doaj   +1 more source

The Significance of Mono‐ and Dual‐Effective Agents in the Development of New Antifungal Strategies

open access: yesChemical Biology &Drug Design, Volume 105, Issue 1, January 2025.
The future of treating challenging fungal infections lies in novel therapies targeting new antifungal targets, overcoming resistance mechanisms, and exploring innovative dual inhibitors. ABSTRACT Invasive fungal infections (IFIs) pose significant challenges in clinical settings, particularly due to their high morbidity and mortality rates.
Cengiz Zobi, Oztekin Algul
wiley   +1 more source

Two simultaneous mycetomas caused by Fusarium verticillioides and Madurella mycetomatis

open access: yesRevista do Instituto de Medicina Tropical de São Paulo
Mycetoma is a chronic granulomatous disease, classified into eumycetoma caused by fungi and actinomycetoma due to aerobic filamentous actinomycetes. Mycetoma can be found in geographic areas near the Tropic of Cancer.
Alexandro Bonifaz   +4 more
doaj   +1 more source

Phaeohyphomycosis caused by Trematosphaeria grisea in an immunocompromised English springer spaniel

open access: yesVeterinary Record Case Reports, Volume 12, Issue 4, December 2024.
Abstract A 10‐year‐old, male, farm‐based springer spaniel that presented with subacute progressive left‐sided central vestibular signs was diagnosed with meningoencephalitis of unknown origin. The patient received prednisolone (2 mg/kg/day orally), ciclosporin (5 mg/kg orally twice a day) and a single infusion of cytarabine (200 mg/m2). Six weeks later,
Erin Brennan   +4 more
wiley   +1 more source

Importance of clinico‐pathologic correlation in rare, chronic infectious diseases: Actinomycetoma misdiagnosed as botryomycosis—A case report

open access: yesClinical Case Reports, Volume 12, Issue 6, June 2024.
Key Clinical Message This case report explores the clinical journey of a patient initially diagnosed with botryomycosis, only to later reveal the underlying and rare condition of actinomycosis. The report highlights the challenges in getting to an accurate diagnosis, emphasizing the importance of considering uncommon pathologies, the utility of multi ...
Josiah Tatenda Masuka   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy